Evidence map›Paper›PMID 40529000›Full record

ArticleJournal of clinical and translational science2025

Implementing electronic health record-based anxiety and depression screening in an epilepsy clinic: Theory-based implementation strategy and pre-post quantitative outcomes using Reach, Effectiveness, Adoption, Implementation, and Maintenance.

Heidi M Munger Clary, Halley B Alexander, Sabina Gesell, Mingyu Wan, Kelly R Conner, Cormac O'Donovan, Jane Boggs, Christian Robles, Maria Sam, Jerryl Christopher and 2 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Heidi M Munger ClaryDepartment of Neurology, Wake Forest University School of Medicine, USA.ORCID https://orcid.org/0000-0002-9889-8351
Halley B AlexanderDepartment of Neurology, Wake Forest University School of Medicine, USA.
Sabina GesellDepartment of Social Sciences and Health Policy, Wake Forest University School of Medicine, USA.ORCID https://orcid.org/0000-0002-1997-9816
Mingyu WanNeuroscience Graduate Program, Wake Forest University, USA.
Kelly R ConnerDepartment of Neurology, Wake Forest University School of Medicine, USA.
Cormac O'DonovanDepartment of Neurology, Wake Forest University School of Medicine, USA.
Jane BoggsDepartment of Neurology, Wake Forest University School of Medicine, USA.
Christian RoblesDepartment of Neurology, Wake Forest University School of Medicine, USA.
Maria SamDepartment of Neurology, Wake Forest University School of Medicine, USA.
Jerryl ChristopherDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, USA.
Christina MariniDepartment of Neurology, New York University Grossman School of Medicine, USA.
Beverly M SnivelyDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Anxiety and depression in epilepsy are common and impactful. Screening with validated measures at every epilepsy visit is a quality measure, yet screening remains limited due to time constraints. Methods: This study aimed to develop an implementation strategy for anxiety and depression screening at an epilepsy center and evaluate it in a pre-post design with RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance). Guided by the Capability, Opportunity, Motivation-Behavior behavior change wheel framework, the strategy incorporated electronic health record tools and support staff activation of electronic screeners during visit check-in. Outcomes were evaluated over five months post-implementation and compared with two 3-month pre-implementation timeframes. Results: Post-implementation, 29.2% of 943 visits met the anxiety and depression screening quality measure, a significant increase from 12.6% immediately pre-implementation (p < 0.0001) and 6.28% before any screening interventions (p < 0.0001). Patients who completed electronic screeners post-implementation were younger than non-completers (mean 39.3 vs. 43.4 years, Conclusions: This framework-based implementation strategy effectively increased screening rates by epilepsy specialists, though challenges remain, including variability across clinic team members and lower reach among older and non-white patients. This study describes a feasible strategy for epilepsy centers to use for improved performance on an American Academy of Neurology quality measure (depression and anxiety screening for patients with epilepsy).

Indexed as

epilepsy quality measuresmental healthPsychiatric comorbidityquality of lifeseizures

Identifiers

PMID40529000
PMCPMC12171918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.